DROXIA 6335 DROXIA 6335 (Droxia 200 mg)
Generic Name: hydroxyurea
Pill with imprint DROXIA 6335 DROXIA 6335 is Green, Capsule-shape and has been identified as Droxia 200 mg. It is supplied by Bristol-Myers Squibb.
Droxia is used in the treatment of anemia, sickle cell; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DROXIA 6335 DROXIA 6335
Droxia
- Generic Name
- hydroxyurea
- Imprint
- DROXIA 6335 DROXIA 6335
- Strength
- 200 mg
- Color
- Green
- Size
- 16.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00003-6335
- Inactive Ingredients
-
citric acid monohydrate,
gelatin,
magnesium stearate,
sodium phosphate,
titanium dioxide,
FD&C Blue No. 1,
FD&C Green No. 3
Note: Inactive ingredients may vary.
More about Droxia (hydroxyurea)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: antimetabolites
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.